Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 170 entries
View as:

Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and Lung Bioavailability of CHF 5993 pMDI Combination in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02359292 Org: User:
Start: 02/28/15 End: 07/31/15 Due: 07/31/16

PK of BDP/FF/GB Single-inhaler Triple Therapy in Japanese vs. Caucasians

Phase: N/A Priority: Normal
NCT ID: NCT03859414 Org: User:
Start: 03/18/19 End: 07/24/19 Due: 07/24/20

A Phase II, 5-way Cross-over Study to Evaluate the Pharmacodynamics of "Nexthaler" Dry Powder Inhaler in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT02000609 Org: User:
Start: 12/31/13 End: 04/30/14 Due: 04/30/15

TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER)

Phase: N/A Priority: Normal
NCT ID: NCT02676089 Org: User:
Start: 04/06/16 End: 05/28/18 Due: 05/28/19

Pharmacokinetic Study of Bramitob® Administered for Inhalation by PARI eFlow® vs PARI LC® PLUS Nebulizer

Phase: N/A Priority: Normal
NCT ID: NCT01116089 Org: User:
Start: 07/31/10 End: 10/31/11 Due: 10/31/12

Effect of Erythromycin on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06395610 Org: User:
Start: 03/28/24 End: 06/18/24 Due: 06/18/25

Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) (CHF 5993)Administered Via Dry Powder Inhaler (DPI) in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT03590379 Org: User:
Start: 06/15/18 End: 03/06/19 Due: 03/06/20

PASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating Fixed Triple Therapy (DPI or pMDI)

Phase: N/A Priority: Normal
NCT ID: NCT05652439 Org: User:
Start: 12/02/22 End: 08/31/26 Due: 08/31/27

Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01911364 Org: User:
Start: 01/31/14 End: 03/31/16 Due: 03/31/17

Fabry Patient's Experience Of PegunigaLsidasE Alfa Monthly Infusion

Phase: N/A Priority: Normal
NCT ID: NCT05186324 Org: User:
Start: 01/26/22 End: 08/31/22 Due: 08/31/23

A Study to Evaluate the Onset of Relief From Methacholine-induced Bronchoconstriction With CHF1535 NEXThaler in Asthmatic Patients.

Phase: N/A Priority: Normal
NCT ID: NCT03108534 Org: User:
Start: 02/28/17 End: 09/19/17 Due: 09/19/18

Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02560610 Org: User:
Start: 09/30/16 End: 08/02/18 Due: 08/02/19

Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06029595 Org: User:
Start: 11/26/23 End: 02/17/27 Due: 02/17/28

Prevalence and Reversibility of Lung Hyperinflation in Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01573364 Org: User:
Start: 02/28/11 End: 01/31/12 Due: 01/31/13

International Cross-sectional and Longitudinal Assessment on Asthma Control (Liaison)

Phase: N/A Priority: Normal
NCT ID: NCT01567280 Org: User:
Start: 05/31/12 End: 10/31/14 Due: 10/31/15

Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT02432833 Org: User:
Start: 05/31/15 End: 01/24/17 Due: 01/24/18

Efficacy and Tolerability of Beclomethasone Dipropionate/Formoterol Single Inhaler in Patients With Mild to Moderate Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00862264 Org: User:
Start: 08/31/04 End: 09/30/05 Due: 09/30/06

Study to Investigate the Pharmacokinetics of CHF 6001 DPI Administered Via Nexthaler® Device or the Capsule for Oral Inhalation Via Aerolizer® Device

Phase: N/A Priority: Normal
NCT ID: NCT02119247 Org: User:
Start: 04/30/14 End: 06/30/14 Due: 06/30/15

Lung Deposition of TRIMBOW® pMDI in Healthy Volunteers, Asthmatic and COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT03795350 Org: User:
Start: 01/14/19 End: 04/03/20 Due: 04/03/21

A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER)

Phase: N/A Priority: Normal
NCT ID: NCT04636801 Org: User:
Start: 07/14/21 End: 01/05/26 Due: 01/05/27

Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD

Phase: N/A Priority: Normal
NCT ID: NCT01917331 Org: User:
Start: 03/31/14 End: 03/31/16 Due: 03/31/17

A 24-wk Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of a New PDE4 Inhibitor in Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT02986321 Org: User:
Start: 12/15/16 End: 01/09/18 Due: 01/09/19

Triple in Asthma Dose Finding

Phase: N/A Priority: Normal
NCT ID: NCT02127866 Org: User:
Start: 04/30/14 End: 03/31/15 Due: 03/31/16

Clinical Pharmacology Study of CHF1535 pMDI 50/6 µg Versus The Free Combination In Asthmatic Children 5-11 Years Old

Phase: N/A Priority: Normal
NCT ID: NCT01848769 Org: User:
Start: 09/30/09 End: 12/31/10 Due: 12/31/11

Biopharmaceutical Study of Glyco pMDI With or Without Charcoal Block vs IV Bolus in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01176851 Org: User:
Start: 07/31/10 End: 10/31/10 Due: 10/31/11